No Detail Found!

Efficacy of argon-helium cryoablation combined with chemotherapy in the treatment of advanced NSCLC

Author(s)
Yongfei Guo Department of Invasive Interventional Therapy, Tianjin Cancer Hospital Airport Hospital, Tianjin City, P.R. China.
Jing Yan Department of Oral and Maxillofacial Surgery, Armed Forces Specialized Medical Center, Tianjin City, P.R. China.
Mao Yang Department of Invasive Interventional Therapy, Tianjin Cancer Hospital Airport Hospital, Tianjin City, P.R. China.
Tongguo Si Department of Invasive Interventional Therapy, Tianjin Cancer Hospital Airport Hospital, Tianjin City, P.R. China.
Abstract
Objective: To explore the eficacy of argon-helium cryoablation (AHC) combined with chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). Methods: A retrospective study was carried out between February 2020 to June 2022 of 85 patients with advanced NSCLC admitted to Tianjin Cancer Hospital Airport Hospital. Patients were categorized into two groups based on whether they had received AHC: patients received chemotherapy treatment alone (chemotherapy group, n=41); patients received chemotherapy combined with AHC (combined group, n=44). Tumor control rate, serum tumor marker levels, quality of life, and median survival time between the two groups were compared. Results: Tumor control rate in the combined group (86.36%) was significantly higher than that in the chemotherapy group (68.29%) (P<0.05). After treatment, the levels of serum cytokeratin 19 fragment (CYFRA21-1), carcinoembryonic antigen (CEA) and glycoprotein antigen 125 (CA125) in the two groups were significantly lower than those before the treatment, and significantly lower in the combined group compared to the chemotherapy group (P<0.05). After the treatment, the quality of life of patients in both groups was significantly higher than before the treatment. Quality of life in the combined group was significantly higher than in the chemotherapy group (P<0.05). One year after treatment, the median survival time of the combined group (10.5 months; 95% CI: 9.775-11.225) was significantly higher than that of the chemotherapy group (9.4 months; 95% CI: 8.55-10.323) (P=0.045). Conclusions: Compared with chemotherapy alone, conventional chemotherapy combined with AHC in the treatment of advanced NSCLC can significantly reduce the levels of serum tumor markers and improve overall treatment eficacy, quality of life and 1-year overall survival rate.
Publication Details
Page(s) 2017-2021
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 9, Year: 2024

Request the full text from PASTIC

Keywords
chemotherapy, advanced NSCLC, Argon-helium cryoablation
References
. .. Cited January, 16 : .
.2020 .. , 10(2) : 793-186.
.2020 .nonsmall cell lung cancer. Curr Opin Oncol, 32(1) : 63-67.
. .. , : .
Sci function. Pak J Med .2023 .. , 10(2) : 6365-408.
Wang C,Qiao W,Jiang Y,Zhu M,Shao J,Wang T .2020 .The landscape of immune checkpoint inhibitor plus chemotherapy versus immunotherapy for advanced non-small-cell lung cancer: A systematic review and meta-analysis. J Cell Physiol, 10(5) : 4913-4927.
Gu P,Liu M,Fan X. .2018 .Clinical effect observation of argon-helium knife combined with pemetrexed on the treatment of patients with advanced non-small cell lung cancer. J Clin Med in Practice, 10(3) : 72-78.
Long ZY,Lu Y,Li M,Chen G,Shi L,Xiao X .2021 .Effective treatment of anlotinib in giant delayed pulmonary metastasis of osteosarcoma: a case report and literature review. Ann Palliat Med, 10(6) : 7073-7082.
.2022 .Health Commission Of The People's Republic Of China N. National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version). Chin J Cancer Res, 03(3) : 9604-206.
Schwartz LH,Litière S,de Vries E,Ford R,Gwyther S,Mandrekar S .2016 .1-Update and clarification: From the RECIST committee. Eur J Cancer, 03 : 132-137.
Chalian H,Töre HG,Horowitz JM,Salem R,Miller FH,Yaghmai V,Radiographics V .2011 .Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0. , 10(7) : 2093-2105.
Hagiwara Y,Shiroiwa T,Taira N,Kawahara T,Konomura K,Noto S,FACT-G onto EQ- S .2020 .-5L index for patients with cancer. Health Qual Life Outcomes, 10(1) : 354.
Jiang W. .2019 .Analysis of the impact of argon helium cryoablation combined with chemotherapy on the short-term and long-term efficacy and gene expression of non-small cell lung cancer patients. J Med Theor Pr, 13(13) : 7585-2047.
Cheng R,Li Y,Su L,Wang L,Cao Y. .2023 .Clinical effect of cold and heat ablation on patients with advanced lung cancer and its influence on immune function. Am J Transl Res, 15(4) : 2939-2948.
Spigel DR,Faivre-Finn C,Gray JE,Vicente D,Planchard D,Paz-Ares L .2022 .Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. J Clin Oncol, 10(12) : 1301-1311.
Chen D,Menon H,Verma V,Guo C,Ramapriyan R,Barsoumian H .2020 .Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials. -000492, 10(1) : .
Sun Z,Chen YQ,Ran BY,Wu Q,Shen W,Kan LN .2023 .Synergistic effects of electroacupuncture and bone marrow stromal cells transplantation therapy in ischemic stroke. Eur Rev Med Pharmacol Sci, 10(8) : 32106-3362.
Wang M,Zhou ZG,Du KP,Li S,Li YD,Gao F .2022 .Safety and efficacy of cryoablation versus radiofrequency ablation for stage Ⅰ non-smallcell lung cancer. j.cn112137-20220109-00060, 10(31) : 2458-2464.
Zhou Q,He H,Wang S,Xiong S. .2020 .Cryoablation with argon-helium knife for the treatment of advanced lung cancer: evaluation of its safety and effectiveness. J Interv Radio, 01(1) : 794X-75.
Duan H,Hu K,Wang J,Chen Y,Zhou Q,Zhou T .2020 .Efficacy and safety of argon-helium cryosurgery combined with chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis. Chinese J Cancer Prevention and Treatment, 03(3) : 230-239.
Xiao Z,Chen Z,Han R,Lu L,Li Z,Lin J .2021 .Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer: A randomized, controlled trial. Medicine (Baltimore), 10(18) : .
Kang J,Zhang C,Zhong WZ .2021 .Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art. Cancer Commun (Lond), 10(4) : 287-302.
0

Citations

0

Downloads

147

Views